Stock Information
Viking Therapeutics Inc (VKTX)
Ticker Symbol: VKTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,665.38 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -4.6622
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -94.56%
Latest News
-
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $65
Tue, Aug 11, 2026 10:50 AM
Key Financials
Financial data not available